Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Fate Therapeutics Shares Rise 10% as First Person Treated with Its Anti-Cancer Therapy

Shares of Fate Therapeutics traded higher after the firm reported it has treated the first patient in a first-in-human trial of FT596 for patients with B-cell malignancies and chronic lymphocytic leukemia. Clinical-stage biopharmaceutical company Fate Thera...
Streetwise Reports | April 7, 2020 |

The 411 on dividends

The dividend is a critical component of the stock market ecosystem that allows companies to reward shareholders for their conviction. To learn more about dividends, check out the video above. Join the discussion: Find out what everybody’s saying...
Lyndsay Malchuk | June 21, 2024 |

Three COVID-19 Patients Treated with PLX Cells

Two programs, one new and the other ongoing, involving Pluristem Therapeutics' regenerative products are reviewed in a Dawson James report. In a March 30 research note, Dawson James Securities analyst Jason Kolbert reported that three high-risk COVID-19 pati...
Streetwise Reports | April 2, 2020 |

Morning Market Outlook for Nov. 8, 2023

Stephen Whiteside of TheUpTrend.com brings us the Morning Market Outlook for Wednesday. Navigate the dynamic world of market moves effortlessly and stay ahead of the game with daily updates on TSX, S&P 500, NASDAQ, gold, crude oil and more. Check out the video above for...
TheUpTrend | November 8, 2023 |

Morning Market Outlook for Nov. 13, 2023

Stephen Whiteside of TheUpTrend.com takes a look at what to watch in the Morning Market Outlook for Monday. Navigate the dynamic world of market moves effortlessly and stay ahead of the game with daily updates on TSX, S&P 500, NASDAQ, gold, crude oil and more. Check out...
TheUpTrend | November 15, 2023 |

Morning Market Outlook for Nov. 16, 2023

Stephen Whiteside of TheUpTrend.com explains the impact of the VIX and looks at Walmart, Metro, Loblaws and more in the Morning Market Outlook for Thursday. Navigate the dynamic world of market moves effortlessly and stay ahead of the game with daily updates on TSX, S&P...
TheUpTrend | November 16, 2023 |

Mesoblast Shares Soar 120% After Reporting 83% Survival Rate in COVID-19 Patients with ARDS

Shares of Mesoblast more than doubled and set a new 52-week high price after the company reported that it achieved a 83% survival rate in New York ventilator-dependent COVID-19 patients with moderate to severe acute respiratory distress syndrome who were treated with its all...
Streetwise Reports | April 27, 2020 |

Buzz on the Bullboards: From innovating traffic enforcement to cancer breakthroughs

The past week on the TSX has been one for the books, with significant gains driven largely by advancements in the technology sector. The S&P 500 and NASDAQ have hit fresh highs, a clear sign of a hungry market bolstered by technology stocks. This momentum has put a spot...
Jonathon Brown | June 20, 2024 |

What is DehydraTECH and how is it revolutionizing solutions in cannabis and alcohol-free beverages?

Hill ( TSXV:HILL ) is a progressive innovation company that utilizes new technologies to provide innovative cannabis solutions and non-alcoholic beverage products globally. It is pioneering the space where craft consumer products meet bioscience by leveraging its deep CP...
Research | June 1, 2023 |

Revenues surge 5x with the continued deployment and expansion of DehydraTECH in US markets

See: Hill Incorporated Releases FY2023 Q3 Financial Results . Hill ( TSXV:HILL ) is a progressive innovation company that utilizes new technologies to provide innovative cannabis solutions and non-alcoholic beverage products globally. It is pioneering the spa...
Research | June 5, 2023 |
1 2 3 4 5 6 7 8 9 10 ...